EJHF Editor-in-Chief
@EJHFEiC
Followers
1K
Following
616
Statuses
242
#EJHF Editor-in-Chief X account. Posts by Professor Michael Böhm and his team. #HFA_ESC #HeartFailure #HF
Joined May 2023
RT @GiuseppeGalati_: 🔥 🗞️ #Beta_blockers in #HFmrEF & #HFpEF >16000 pts ✅ Association with ⬇️ #CV ☠️ & #HHF 🏥 in both groups ✳️ Be car…
0
8
0
🗞️ Beta-blockers in #HF with mildy reduced & preserved #LVEF
@ESC_Journals @GiuseppeGalati_
@AmrAbdin10 @HanCardiomd
@HFA_President
0
4
21
RT @ESC_Journals: 🚨 #FAIRHF2: double-blind RCT w 1105 pts with #HFrEF & iron deficiency. Over ≥2 y, pts receive placebo-controlled IV iron.…
0
9
0
Withdrawal of medical therapy for heart failure after rhythm control in arrhythmia-induced #cardiomyopathy—a call for caution @ESC_Journals
@HanCardiomd @AmrAbdin10 @GiuseppeGalati_
4
61
212
RT @GiuseppeGalati_: 🔥 #FAIR_HF2 : High dose IV #FerricCarboxymaltose in iron deficiency & #HFrEF to reduce morbidity & mortality 🍀 Ratio…
0
11
0
🗞️ #FAIR_HF2 (DZHK05): #FerricCarboxymaltose assessment of morbidity & mortality in iron deficiency & #HF
@ESC_Journals @GiuseppeGalati_
@AmrAbdin10 @HanCardiomd
@HFA_President
0
11
39
Continuous risk monitoring and management of heart failure: Rationale and design of the #ALLEVIATE-HF trial @JavedButler1 @ShahzebKhanMD
@HanCardiomd @AmrAbdin10 @GiuseppeGalati_ #EJHF
0
9
30
RT @GiuseppeGalati_: 🔥 🗞️ #CANVAS & #CREDENCE: #Canagliflozin ⬇️ oral loop diuretic intensification in patients with #T2DM Another proof…
0
10
0
🗞️ #CANVAS & #CREDENCE: #Canagliflozin reduces oral loop diuretic intensification in patients with #T2DM
@ESC_Journals @GiuseppeGalati_
@AmrAbdin10 @HanCardiomd
@HFA_President
1
6
19
RT @JBauersachsMD: 🔥hot of the press: Final Protocol of #DIGIT_HF with key amendments of Study design. Digitoxin in #HFrEF. Looking forward…
0
3
0
Remote patient monitoring in heart failure: A comprehensive meta-analysis of effective programme components for hospitalization and mortality reduction #EJHF
@ESC_Journals @HanCardiomd @GiuseppeGalati_ @AmrAbdin10
1
8
23
RT @GiuseppeGalati_: 🔥 #FIDELITY subanalysis: #finerenone efficacy & Safety in #CKD & #T2DM, by diuretic use ~ 13.000 pts No difference wi…
0
9
0
🗞️ #FIDELITY subanalysis: Efficacy & Safety of #finerenone in #CKD & #T2DM, by diuretic use @ESC_Journals @GiuseppeGalati_
@AmrAbdin10 @HanCardiomd
@HFA_President
0
10
23
#Sacubitril/valsartan versus valsartan initiation in patients naïve to #RASI : Insights from #PARAGLIDE-HF @robmentz @ShelleyZieroth
#EJHF @ESC_Journals @HanCardiomd @AmrAbdin10 @GiuseppeGalati_
1
16
43
RT @GiuseppeGalati_: 🔥 #SUGAR_DM_HF: #CMR estimated PCWP & congestion markers, & effect of #empagliflozin in #HFrEF in prediabets & T2DM…
0
17
0
🗞️ SUGAR-DM-HF #CMR estimated PCWP & congestion markers, and effect of #empagliflozin in #HFrEF with dysglycaemia @ESC_Journals @GiuseppeGalati_
@AmrAbdin10 @HanCardiomd
@HFA_President
0
14
34
RT @ESC_Journals: T-TEER in patients with #CIED is safe + effective option for relevant TR 👉 @AmrAbdin10 @Giusepp…
0
12
0
RT @HanCardiomd: #PARADISE MI : Analysis of 5589 AMI patients with baseline BMI data 📌Lowest CV death/HF rate: Overweight patients (BMI 25…
0
7
0
Association between #BMI and clinical outcomes in patients with #AMI and reduced systolic function: Analysis of #PARADISE-MI trial data #EJHF
@HanCardiomd @AmrAbdin10 @GiuseppeGalati_
0
6
14